Wisniewski J, Wiecek K, Ali H, Pyrc K, Kula-Pacurar A, Wagner M
iScience. 2024; 27(11):111222.
PMID: 39559761
PMC: 11570469.
DOI: 10.1016/j.isci.2024.111222.
van Pul L, Stunnenberg M, Kroeze S, van Dort K, Boeser-Nunnink B, Harskamp A
PLoS One. 2024; 19(10):e0298472.
PMID: 39356699
PMC: 11446443.
DOI: 10.1371/journal.pone.0298472.
Han R, Su L, Cheng L
Vaccines (Basel). 2024; 12(9).
PMID: 39340042
PMC: 11436046.
DOI: 10.3390/vaccines12091012.
Poveda E, Fitzgerald W, Alonso-Dominguez J, Aguayo-Arjona J, Marino A, Alvarez H
Front Immunol. 2024; 15:1446730.
PMID: 39267749
PMC: 11390527.
DOI: 10.3389/fimmu.2024.1446730.
Salgado M, Migueles S, Yu X, Martinez-Picado J
Med. 2024; 5(9):1071-1082.
PMID: 39013460
PMC: 11411266.
DOI: 10.1016/j.medj.2024.06.008.
Helper T cell immunity in humans with inherited CD4 deficiency.
Guerin A, Moncada-Velez M, Jackson K, Ogishi M, Rosain J, Mancini M
J Exp Med. 2024; 221(5).
PMID: 38557723
PMC: 10983808.
DOI: 10.1084/jem.20231044.
IFNα induces CCR5 in CD4 T cells of HIV patients causing pathogenic elevation.
Le Buanec H, Schiavon V, Merandet M, How-Kit A, Song H, Bergerat D
Commun Med (Lond). 2024; 4(1):52.
PMID: 38504093
PMC: 10951336.
DOI: 10.1038/s43856-024-00453-7.
TScan-II: A genome-scale platform for the de novo identification of CD4 T cell epitopes.
Dezfulian M, Kula T, Pranzatelli T, Kamitaki N, Meng Q, Khatri B
Cell. 2023; 186(25):5569-5586.e21.
PMID: 38016469
PMC: 10841602.
DOI: 10.1016/j.cell.2023.10.024.
Targeting the HIV reservoir: chimeric antigen receptor therapy for HIV cure.
Li S, Wang H, Guo N, Su B, Lambotte O, Zhang T
Chin Med J (Engl). 2023; 136(22):2658-2667.
PMID: 37927030
PMC: 10684145.
DOI: 10.1097/CM9.0000000000002904.
Population-level analysis of natural control of HIV infection in Zambia and South Africa: HPTN 071 (PopART).
Grant-McAuley W, Piwowar-Manning E, Clarke W, Breaud A, Zewdie K, Moore A
J Int AIDS Soc. 2023; 26(10):e26179.
PMID: 37886843
PMC: 10603557.
DOI: 10.1002/jia2.26179.
Molecular insights into the HLA-B35 molecules' classification associated with HIV control.
Lobos C, Chatzileontiadou D, Sok B, Almedia C, Halim H, DOrsogna L
Immunol Cell Biol. 2023; 102(1):34-45.
PMID: 37811811
PMC: 10952751.
DOI: 10.1111/imcb.12698.
An active HIV reservoir during ART is associated with maintenance of HIV-specific CD8 T cell magnitude and short-lived differentiation status.
Takata H, Mitchell J, Pacheco J, Pagliuzza A, Pinyakorn S, Buranapraditkun S
Cell Host Microbe. 2023; 31(9):1494-1506.e4.
PMID: 37708852
PMC: 10564289.
DOI: 10.1016/j.chom.2023.08.012.
A metagenome-wide association study of HIV disease progression in HIV controllers.
Real L, Saez M, Corma-Gomez A, Gonzalez-Perez A, Thorball C, Ruiz R
iScience. 2023; 26(7):107214.
PMID: 37456859
PMC: 10339206.
DOI: 10.1016/j.isci.2023.107214.
An open label randomized controlled trial of atorvastatin versus aspirin in elite controllers and antiretroviral-treated people with HIV.
Mystakelis H, Wilson E, Laidlaw E, Poole A, Krishnan S, Rupert A
AIDS. 2023; 37(12):1827-1835.
PMID: 37450602
PMC: 10481929.
DOI: 10.1097/QAD.0000000000003656.
Comparison of the Biological Basis for Non-HIV Transmission to HIV-Exposed Seronegative Individuals, Disease Non-Progression in HIV Long-Term Non-Progressors and Elite Controllers.
Hokello J, Tyagi P, Dimri S, Sharma A, Tyagi M
Viruses. 2023; 15(6).
PMID: 37376660
PMC: 10301403.
DOI: 10.3390/v15061362.
Bibliometric and visualized analysis of elite controllers based on CiteSpace: landscapes, hotspots, and frontiers.
Yuan X, Lai Y
Front Cell Infect Microbiol. 2023; 13:1147265.
PMID: 37124043
PMC: 10130382.
DOI: 10.3389/fcimb.2023.1147265.
Immunomodulatory Activity of the Tyrosine Kinase Inhibitor Dasatinib to Elicit NK Cytotoxicity against Cancer, HIV Infection and Aging.
Rodriguez-Agustin A, Casanova V, Grau-Exposito J, Sanchez-Palomino S, Alcami J, Climent N
Pharmaceutics. 2023; 15(3).
PMID: 36986778
PMC: 10055786.
DOI: 10.3390/pharmaceutics15030917.
Contribution of the HIV-1 Envelope Glycoprotein to AIDS Pathogenesis and Clinical Progression.
Valenzuela-Fernandez A, Cabrera-Rodriguez R, Casado C, Perez-Yanes S, Pernas M, Garcia-Luis J
Biomedicines. 2022; 10(9).
PMID: 36140273
PMC: 9495913.
DOI: 10.3390/biomedicines10092172.
Protective HLA-B57: T cell and natural killer cell recognition in HIV infection.
Lobos C, Downing J, DOrsogna L, Chatzileontiadou D, Gras S
Biochem Soc Trans. 2022; 50(5):1329-1339.
PMID: 36111814
PMC: 9704518.
DOI: 10.1042/BST20220244.
Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control.
Bernard N, Kant S, Kiani Z, Tremblay C, Dupuy F
Front Immunol. 2022; 13:879124.
PMID: 35720328
PMC: 9205404.
DOI: 10.3389/fimmu.2022.879124.